Zhen-Hua Wang, Yu Jiang, Tao Fang, Jin-Qiu Li, Tai Wang, Chun-Yang Zhou, Rong Wang, Wen-Tao Cai, Hai Liu
{"title":"Cardiovascular health score and its association with postoperative delirium: evidence from the Kailuan study.","authors":"Zhen-Hua Wang, Yu Jiang, Tao Fang, Jin-Qiu Li, Tai Wang, Chun-Yang Zhou, Rong Wang, Wen-Tao Cai, Hai Liu","doi":"10.3389/fmed.2025.1577424","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Identifying modifiable risk factors for postoperative delirium (POD) is essential for prevention and management. The Ideal Cardiovascular Health Score (CHS), a composite measure of cardiovascular health, has been shown to reduce the risk of various chronic diseases. However, its association with POD has not been extensively explored. This study aims to examine the relationship between CHS and the risk of POD in a cohort of surgical patients.</p><p><strong>Methods: </strong>Data from the Kailuan Study, a large longitudinal cohort, were used for this analysis. A total of 1,082 participants aged 18-98 years, who underwent non-cardiac surgery under general anesthesia from 2016 to 2021, were included. The CHS was calculated based on seven cardiovascular health metrics: smoking status, body mass index (BMI), physical activity, diet, blood pressure, fasting blood glucose (FBG), and total cholesterol (TC). POD was diagnosed using the Confusion Assessment Method (CAM). Multivariable logistic regression was employed to assess the association between CHS scores and POD, adjusting for potential confounders.</p><p><strong>Results: </strong>Among the 1,082 participants, 120 developed POD. Higher CHS scores were inversely associated with the risk of POD. Participants with a CHS ≥ 10 had 55% lower odds of developing POD compared to those with a CHS ≤ 7 (OR = 0.45; 95% CI: 0.23-0.89). This protective effect was observed across various subgroups, including age, sex, and alcohol consumption status. Specific CHS components, such as normal blood pressure (OR = 0.49; 95% CI: 0.31-0.78) and FBG < 5.6 mmol/L (OR = 0.65; 95% CI: 0.47-0.94), were independently associated with reduced POD risk.</p><p><strong>Conclusion: </strong>A higher CHS score is associated with a lower risk of POD, highlighting the potential protective role of cardiovascular health in preventing postoperative complications.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1577424"},"PeriodicalIF":3.1000,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12283702/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1577424","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Identifying modifiable risk factors for postoperative delirium (POD) is essential for prevention and management. The Ideal Cardiovascular Health Score (CHS), a composite measure of cardiovascular health, has been shown to reduce the risk of various chronic diseases. However, its association with POD has not been extensively explored. This study aims to examine the relationship between CHS and the risk of POD in a cohort of surgical patients.
Methods: Data from the Kailuan Study, a large longitudinal cohort, were used for this analysis. A total of 1,082 participants aged 18-98 years, who underwent non-cardiac surgery under general anesthesia from 2016 to 2021, were included. The CHS was calculated based on seven cardiovascular health metrics: smoking status, body mass index (BMI), physical activity, diet, blood pressure, fasting blood glucose (FBG), and total cholesterol (TC). POD was diagnosed using the Confusion Assessment Method (CAM). Multivariable logistic regression was employed to assess the association between CHS scores and POD, adjusting for potential confounders.
Results: Among the 1,082 participants, 120 developed POD. Higher CHS scores were inversely associated with the risk of POD. Participants with a CHS ≥ 10 had 55% lower odds of developing POD compared to those with a CHS ≤ 7 (OR = 0.45; 95% CI: 0.23-0.89). This protective effect was observed across various subgroups, including age, sex, and alcohol consumption status. Specific CHS components, such as normal blood pressure (OR = 0.49; 95% CI: 0.31-0.78) and FBG < 5.6 mmol/L (OR = 0.65; 95% CI: 0.47-0.94), were independently associated with reduced POD risk.
Conclusion: A higher CHS score is associated with a lower risk of POD, highlighting the potential protective role of cardiovascular health in preventing postoperative complications.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world